Furthermore, GSR and GPX genes have already been reported as essential features to block EMT in melanoma cells, cervical cancer, hepatocellular carcinoma, gastric, pancreatic, breast, and colon cancers (23–26, 30, 42, 43). This evidence concerns the gene GSR and colonic neoplasm.